American father raising money for sick kids dies on Mt. Makalu
An American mountaineer who was climbing to raise funds for a children's cancer charity has died on a Himalayan peak while preparing for his summit attempt.
Alexander Pancoe, 39, from Illinois, suffered a suspected cardiac arrest late Sunday night at Camp II on Mt Makalu in Nepal, the world's fifth-highest mountain.
The highly experienced climber, who was a brain tumor survivor, had just completed an acclimatization rotation to Camp III.
'Alex felt uncomfortable while he returned from the camp three of the 8,485-metre mountain completing his acclimatization rotation,' Iswari Paudel of Himalayan Guides confirmed to the Himalayan Times.
Expedition officials told the Independent that Pancoe was preparing to rest for the night when he suddenly felt unwell.
His teammates attempted to revive him for over an hour, yet he tragically remained unresponsive.
The father of two young children was on the challenging climb to raise $27,838 (the height of Mt Makalu in feet) for Lurie Children's pediatric blood cancer program in his hometown of Chicago.
Pancoe had also been fighting chronic myeloid leukemia at the time of his death.
He was the founder of Peaks of Mind, a non profit that combines climbing to 'raise awareness and make a difference.'
The father of two young children was on the challenging climb to raise $27,838 (the height of Mt Makalu in feet) for Lurie Children's pediatric blood cancer program in his hometown of Chicago
'In 2005, I was diagnosed with a brain tumor and successfully operated on at Lurie Children's Hospital. 20 years later I have had no complications,' he explained on the Peaks of Mind's website.
'In 2016, I went on a life-changing adventure to climb Mt. Kilimanjaro. In the years following, I fell in love with adventure, overcoming fear, and pushing my physical and mental limits.'
The experienced climber had already achieved major feats before his final expedition - while raising funds for sick kids along the way.
'I got this crazy idea in my head (the crazy is something the surgery didn't change) to pursue the Explorer's Grand Slam - a challenge that involves climbing the 7 summits and skiing to both the North and South Pole.'
'While pursuing this dream, I raised awareness, shared other patients' journeys, and raise funds for pediatric brain tumor research at Lurie Children's - giving back to the amazing institution that saved his life years prior.'
He had previous close calls. During a 2023 climb of Ama Dablam in the Himalayas Pancoe was when he first noticed serious health problems.
'It was a wild few years filled with adventure, a near fatal climbing injury that required a blackhawk helicopter rescue, and lots of climbing! In 2019, upon summiting Everest and Denali, I became just the 15th American and one of 75 people in the world to complete the Grand Slam, raising almost $500,000 in the process for Lurie Children's.'
'In 2023. while climbing Ama Dablam, a challenging climb in the Himalayan range, I became extremely hypoxic and struggled with the altitude. Several months later I was diagnosed with Chronic Myeloid Leukemia and learned my body had been unable to make the red bloods cells necessary to acclimate at altitude.'
But despite the devastating diagnosis, Pancoe was determined to continue his mission.
'CML is a lifelong cancer and after almost two years of receiving treatment to manage it - I am going to be attempting to climb Makalu, the 5th highest mountain the world and raise $27,838 (the height if Makalu in feet) for Lurie Children's pediatric blood cancer program.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
an hour ago
- Daily Mail
Urgent nationwide recall of 1.7m popular home appliances as 17 people are poisoned
A wildly popular home appliance used in millions of American households has been urgently recalled after it was found to be exposing people to dangerous mold growth. Officials say at least 152 customers have reported mold contamination in the units, with 17 of them falling ill. An investigation is underway to determine the source and full scope of the outbreak. Midea, a major appliance manufacturer, pulled approximately 1.7 million U and U+ window air conditioners from the US market on June 5, following reports of mold contamination. The brand names included in the recall are: Midea, Comfort Aire, Danby, Frigidaire, Insignia, Keystone, LBG Products, Mr Cool, Perfect Aire, and Sea Breeze. These names appear on the front of the units, while the model number can be found on a label located on the front right side when facing the appliance. The products were sold through major retailers both in physical stores and online, including Costco, Best Buy, Home Depot, Menards, and from March 2020 to May 2025 for $280 to $500. Each unit is white and measures approximately 22 inches wide by 14 inches high. According to the CPSC, they were sold under 13 different brand names. The US Consumer Product Safety Commission (CPSC) issued a warning that the affected units have drainage issues, which can cause water to pool inside the machines, creating the perfect conditions for mold growth. Pictured are the recalled air conditioners and model numbers 'Pooled water in the air conditioners can fail to drain quickly enough, which can lead to mold growth,' the CPSC said in a statement. Exposure to mold can result in respiratory infections, allergic reactions, and other health issues, especially for individuals with underlying health conditions. Mold is a type of fungus that thrives in moist environments and can release harmful allergens or toxins into the air. Affected customers are eligible for either a free repair or a refund, depending on the model and date of purchase. 'Consumers who want a refund will be asked to return the unit using a free shipping label, or they may submit a photograph showing that they've cut the unplugged power cord to qualify for the refund,' the CPSC explained. Federal officials are urging consumers to stop using the recalled units immediately, particularly if anyone in the household is experiencing symptoms consistent with mold exposure. The recalled units come in three sizes, capable of cooling rooms at 8,000, 10,000, or 12,000 British Thermal Units (BTUs). They were manufactured in China and Thailand by GD Midea Air-Conditioning Co, Ltd. Each unit was sold with a remote control and can also be operated via a mobile app. The specific issue lies in the internal drainage system. If the reservoir does not empty quickly enough, stagnant water can accumulate, leading to mold growth inside the appliance. As the mold builds up, the unit may begin dispersing spores into the air, posing a health hazard for anyone nearby. Mold exposure poses a heightened risk for individuals with chronic respiratory issues such as asthma, lung disease, or weakened immune systems. According to the CDC, common symptoms of mold exposure include a stuffy nose, wheezing, fatigue, and red or itchy eyes or skin. Severe cases may result in fever or difficulty breathing. 'People with asthma or who are allergic to mold may have severe reactions,' the CDC states. 'Immunocompromised people and people with chronic lung disease may get infections in their lungs from mold.' Consumers who choose to continue using their air conditioner while waiting for a repair should follow the safety inspection instructions provided on Midea's recall page. To begin the refund or repair process, visit the Midea recall website or call 888-345-0251 between 8 am and 5 pm ET, Monday through Friday. The official recall number issued by the Consumer Product Safety Commission is 25-320.
Powys County Times
3 hours ago
- Powys County Times
D-Day landings boosted by import of ‘wonder drug' to Britain, archives reveal
The D-Day landings were boosted by the import from America of a 'wonder drug', unearthed documents reveal. Production of the antibiotic penicillin had struggled to take hold at a large scale in Britain, despite being discovered in 1928 in London by Sir Alexander Fleming. Attempts to produce substantial quantities of medicine from the bacteria-killing mould had not been achieved by the start of the Second World War. Then prime minister Sir Winston Churchill became increasingly frustrated that Britain had not been able to produce enough penicillin in the preparations for the Normandy landings in 1944. Official papers released by the National Archive – containing handwritten notes by Sir Winston – highlight efforts to boost quantities of the antibiotic, with Britain eventually forced to import it from America. The documents were released ahead of the 81st anniversary of D-Day, the Allied invasion of Normandy on June 6, 1944. In one report on February 19, after the issue had been raised in the House of Commons, Sir Winston scrawled in red ink on a Ministry of Supply report noting the Americans were producing greater quantities: 'I am sorry we can't produce more.' On another paper, he complained: 'Your report on penicillin showing that we are only to get about one tenth of the expected output this year, is very disappointing.' Elsewhere in the same file he instructs: 'Let me have proposals for a more abundant supply from Great Britain.' With preparations for D-Day ramped up, efforts to deliver enough American-made penicillin for frontline military personnel soon became a matter of urgency. Decisions needed to be made on the quantities of antibiotic imported, how much to administer to individual patients, and how to get medical staff trained in time. Most British doctors did not know how to issue penicillin – until this point, doctors had nothing available to treat infections like pneumonia and many people died of blood poisoning after minor injuries because no drug existed that could cure them. Early in January 1944, Prof FR Fraser, the Ministry of Health's adviser on the organisation of wartime hospitals, wrote that 50,000-100,000 wounded could be expected from the Second Front. He proposed the Emergency Medical Services might need as many as five billion units of penicillin per month for this. Further documents show discussions on whether the antibiotic should be supplied as calcium or sodium salts, or in tablet form. Ultimately, it was agreed powdered calcium salts would be issued for superficial wounds and sodium salts for use in deep wounds. On May 24 1944, less than a fortnight before D-Day, Prof Fraser reported: 'Sufficient supplies of penicillin are now available for the treatment of battle casualties in EMS hospitals, but not for ordinary civilian patients.' Plans were made for casualties from the frontline in France to be brought back to coastal hospitals in Britain for treatment. A week before D-Day, on May 30 1944, hospitals were instructed to treat battlefield patients en route: 'In an endeavour to prevent the development of gas gangrene and sepsis in wounds the War Office have arranged for the treatment of selected cases by penicillin to be commenced as soon after injury as possible.' Injections of penicillin were to be given to them at intervals of not more than five hours and patients would be wearing a yellow label with the letters 'PEN'. The time and size of penicillin doses should be written on it, they were told. Dr Jessamy Carlson, modern records specialist at the National Archives, said: 'File MH 76/184 gives a glimpse into the extraordinary levels of preparation undertaken in advance of the D-Day landings. 'Only six weeks before, penicillin is just reaching our shores in quantities which will allow it to play a major role in improving the outcomes for service personnel wounded in action.' As Allied forces made inroads into Europe, restrictions on the use of penicillin for civilians began to relax, but only in special cases. In July 1944, Ronald Christie, professor of medicine, wrote to Prof Fraser to tell him: 'The War Office approves of American penicillin being used for medical conditions in service patients and for air raid casualties among civilians.' On the home front, demand for the new 'wonder' drug began to increase, according the National Archives. It was decided that penicillin for civilians should only be supplied to larger hospitals where the staff had been properly trained to administer it.
The Herald Scotland
4 hours ago
- The Herald Scotland
D-Day landings boosted by import of ‘wonder drug' to Britain, archives reveal
Attempts to produce substantial quantities of medicine from the bacteria-killing mould had not been achieved by the start of the Second World War. Then prime minister Sir Winston Churchill became increasingly frustrated that Britain had not been able to produce enough penicillin in the preparations for the Normandy landings in 1944. Official papers released by the National Archive – containing handwritten notes by Sir Winston – highlight efforts to boost quantities of the antibiotic, with Britain eventually forced to import it from America. The documents were released ahead of the 81st anniversary of D-Day, the Allied invasion of Normandy on June 6, 1944. Official papers highlight the efforts to boost quantities of penicillin (The National Archives/PA) In one report on February 19, after the issue had been raised in the House of Commons, Sir Winston scrawled in red ink on a Ministry of Supply report noting the Americans were producing greater quantities: 'I am sorry we can't produce more.' On another paper, he complained: 'Your report on penicillin showing that we are only to get about one tenth of the expected output this year, is very disappointing.' Elsewhere in the same file he instructs: 'Let me have proposals for a more abundant supply from Great Britain.' With preparations for D-Day ramped up, efforts to deliver enough American-made penicillin for frontline military personnel soon became a matter of urgency. Decisions needed to be made on the quantities of antibiotic imported, how much to administer to individual patients, and how to get medical staff trained in time. Most British doctors did not know how to issue penicillin – until this point, doctors had nothing available to treat infections like pneumonia and many people died of blood poisoning after minor injuries because no drug existed that could cure them. Royal Navy D-Day veteran John Dennett, 101, at the British Normandy Memorial in Ver-sur-Mer to mark the 81st anniversary of the landings (Gareth Fuller/PA) Early in January 1944, Prof FR Fraser, the Ministry of Health's adviser on the organisation of wartime hospitals, wrote that 50,000-100,000 wounded could be expected from the Second Front. He proposed the Emergency Medical Services might need as many as five billion units of penicillin per month for this. Further documents show discussions on whether the antibiotic should be supplied as calcium or sodium salts, or in tablet form. Ultimately, it was agreed powdered calcium salts would be issued for superficial wounds and sodium salts for use in deep wounds. On May 24 1944, less than a fortnight before D-Day, Prof Fraser reported: 'Sufficient supplies of penicillin are now available for the treatment of battle casualties in EMS hospitals, but not for ordinary civilian patients.' Plans were made for casualties from the frontline in France to be brought back to coastal hospitals in Britain for treatment. A week before D-Day, on May 30 1944, hospitals were instructed to treat battlefield patients en route: 'In an endeavour to prevent the development of gas gangrene and sepsis in wounds the War Office have arranged for the treatment of selected cases by penicillin to be commenced as soon after injury as possible.' Military reenactors watch the sunrise over Gold Beach in Arromanches-les-Bains, Normandy, on the 81st anniversary of the D-Day landings (Gareth Fuller/PA) Injections of penicillin were to be given to them at intervals of not more than five hours and patients would be wearing a yellow label with the letters 'PEN'. The time and size of penicillin doses should be written on it, they were told. Dr Jessamy Carlson, modern records specialist at the National Archives, said: 'File MH 76/184 gives a glimpse into the extraordinary levels of preparation undertaken in advance of the D-Day landings. 'Only six weeks before, penicillin is just reaching our shores in quantities which will allow it to play a major role in improving the outcomes for service personnel wounded in action.' As Allied forces made inroads into Europe, restrictions on the use of penicillin for civilians began to relax, but only in special cases. In July 1944, Ronald Christie, professor of medicine, wrote to Prof Fraser to tell him: 'The War Office approves of American penicillin being used for medical conditions in service patients and for air raid casualties among civilians.' On the home front, demand for the new 'wonder' drug began to increase, according the National Archives. It was decided that penicillin for civilians should only be supplied to larger hospitals where the staff had been properly trained to administer it. Only in 1946 did it become fully available for the general public.
